Wall Street analysts expect Stericycle Inc (NASDAQ:SRCL) to post $868.04 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Stericycle’s earnings, with the lowest sales estimate coming in at $850.00 million and the highest estimate coming in at $889.28 million. Stericycle reported sales of $882.77 million in the same quarter last year, which would indicate a negative year over year growth rate of 1.7%. The firm is expected to report its next earnings results on Wednesday, November 14th.

According to Zacks, analysts expect that Stericycle will report full year sales of $3.52 billion for the current year, with estimates ranging from $3.49 billion to $3.58 billion. For the next fiscal year, analysts forecast that the firm will post sales of $3.57 billion per share, with estimates ranging from $3.50 billion to $3.64 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Stericycle.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, August 2nd. The business services provider reported $1.17 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.13 by $0.04. Stericycle had a return on equity of 14.04% and a net margin of 5.03%. The business had revenue of $883.30 million during the quarter, compared to analysts’ expectations of $896.62 million. During the same period in the previous year, the business posted $1.15 earnings per share. The firm’s revenue for the quarter was down 3.7% compared to the same quarter last year.

A number of research firms recently issued reports on SRCL. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a report on Thursday. BMO Capital Markets cut their price target on Stericycle from $71.00 to $63.00 and set a “market perform” rating for the company in a report on Monday, August 6th. Robert W. Baird reaffirmed a “hold” rating and issued a $70.00 price target on shares of Stericycle in a report on Friday, August 3rd. Jefferies Financial Group set a $75.00 price target on Stericycle and gave the company a “buy” rating in a report on Thursday, August 2nd. Finally, BidaskClub upgraded Stericycle from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 31st. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $71.71.

Shares of Stericycle stock traded down $0.05 during trading on Friday, reaching $61.42. The company’s stock had a trading volume of 591,900 shares, compared to its average volume of 932,709. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.87. Stericycle has a one year low of $56.64 and a one year high of $76.73. The stock has a market capitalization of $5.28 billion, a price-to-earnings ratio of 14.17, a P/E/G ratio of 1.43 and a beta of 0.42.

In related news, Director Mark C. Miller sold 65,314 shares of Stericycle stock in a transaction dated Thursday, July 5th. The stock was sold at an average price of $65.08, for a total value of $4,250,635.12. Following the completion of the sale, the director now directly owns 224,052 shares in the company, valued at $14,581,304.16. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Daniel Ginnetti sold 5,000 shares of Stericycle stock in a transaction dated Friday, July 27th. The stock was sold at an average price of $70.75, for a total value of $353,750.00. Following the completion of the sale, the chief financial officer now owns 11,490 shares of the company’s stock, valued at $812,917.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 204,165 shares of company stock valued at $13,278,327. Corporate insiders own 3.50% of the company’s stock.

A number of hedge funds have recently made changes to their positions in SRCL. Whittier Trust Co. grew its position in shares of Stericycle by 362.6% during the 2nd quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock worth $129,000 after buying an additional 852 shares during the period. Zions Bancorporation acquired a new position in shares of Stericycle during the 1st quarter worth about $122,000. Federated Investors Inc. PA grew its position in shares of Stericycle by 129.5% during the 1st quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock worth $122,000 after buying an additional 1,178 shares during the period. Dupont Capital Management Corp grew its position in shares of Stericycle by 102.2% during the 2nd quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock worth $136,000 after buying an additional 1,056 shares during the period. Finally, NumerixS Investment Technologies Inc grew its position in shares of Stericycle by 285.0% during the 2nd quarter. NumerixS Investment Technologies Inc now owns 2,695 shares of the business services provider’s stock worth $174,000 after buying an additional 1,995 shares during the period. Hedge funds and other institutional investors own 97.31% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Further Reading: Trading Strategy

Get a free copy of the Zacks research report on Stericycle (SRCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.